These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 12549928)

  • 1. Cell surface heparan sulfate participates in CXCL1-induced signaling.
    Wang D; Sai J; Richmond A
    Biochemistry; 2003 Feb; 42(4):1071-7. PubMed ID: 12549928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK1 kinase is required for CXCL1-induced chemotaxis.
    Wang D; Sai J; Carter G; Sachpatzidis A; Lolis E; Richmond A
    Biochemistry; 2002 Jun; 41(22):7100-7. PubMed ID: 12033944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
    Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
    J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway.
    Chandrasekar B; Melby PC; Sarau HM; Raveendran M; Perla RP; Marelli-Berg FM; Dulin NO; Singh IS
    J Biol Chem; 2003 Feb; 278(7):4675-86. PubMed ID: 12468547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis.
    Zernecke A; Weber KS; Erwig LP; Kluth DC; Schröppel B; Rees AJ; Weber C
    J Immunol; 2001 May; 166(9):5755-62. PubMed ID: 11313419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation.
    Merz D; Liu R; Johnson K; Terkeltaub R
    J Immunol; 2003 Oct; 171(8):4406-15. PubMed ID: 14530367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
    Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
    J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB.
    Nilsson G; Mikovits JA; Metcalfe DD; Taub DD
    Blood; 1999 May; 93(9):2791-7. PubMed ID: 10216072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway.
    Wang D; Richmond A
    J Biol Chem; 2001 Feb; 276(5):3650-9. PubMed ID: 11062239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.
    Yang W; Schraw WP; Mueller SG; Richmond A
    Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling.
    Feniger-Barish R; Belkin D; Zaslaver A; Gal S; Dori M; Ran M; Ben-Baruch A
    Blood; 2000 Mar; 95(5):1551-9. PubMed ID: 10688807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
    Ahuja SK; Murphy PM
    J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
    Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
    Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction.
    Yang W; Wang D; Richmond A
    J Biol Chem; 1999 Apr; 274(16):11328-33. PubMed ID: 10196223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXC chemokines suppress proliferation of myeloid progenitor cells by activation of the CXC chemokine receptor 2.
    Sanchez X; Suetomi K; Cousins-Hodges B; Horton JK; Navarro J
    J Immunol; 1998 Jan; 160(2):906-10. PubMed ID: 9551928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrete steps in binding and signaling of interleukin-8 with its receptor.
    Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
    J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide N-oxides as CXCR2 antagonists.
    Cutshall NS; Ursino R; Kucera KA; Latham J; Ihle NC
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1951-4. PubMed ID: 11459668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
    Inngjerdingen M; Rolstad B; Ryan JC
    J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
    Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ
    Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
    Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
    Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.